Cryoglobulinaemia

D Roccatello, D Saadoun, M Ramos-Casals… - Nature Reviews …, 2018 - nature.com
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis

T Barba, R Fort, V Cottin, S Provencher, I Durieu… - Autoimmunity …, 2019 - Elsevier
Objective Interstitial lung disease (ILD) is the most severe complication of idiopathic
inflammatory myositis (IIM), resulting in significant increase in morbidity and mortality and for …

EASL recommendations on treatment of hepatitis C 2018

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2018 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis

D Saadoun, S Pol, Y Ferfar, L Alric, C Hezode… - Gastroenterology, 2017 - Elsevier
Circulating mixed cryoglobulins are detected in 40%–60% of patients with hepatitis C virus
(HCV) infection, and overt cryoglobulinemia vasculitis (CryoVas) develops in approximately …

[HTML][HTML] International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement

AL Zignego, M Ramos-Casals, C Ferri, D Saadoun… - Autoimmunity …, 2017 - Elsevier
Hepatitis C virus (HCV) is both hepatotrophic and lymphotropic virus that causes liver as
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …

Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure

M Bonacci, S Lens, Z Mariño, MC Londoño… - Gastroenterology, 2018 - Elsevier
Patients with hepatitis C virus–associated cryoglobulinemic vasculitis (HCV-CV) have high
rates of clinical remission after treatment with direct-acting antivirals (DAAs), but circulating …

Long-term efficacy of interferon-free antiviral treatment regimens in patients with hepatitis C virus–associated cryoglobulinemia vasculitis

P Cacoub, SNS Ahmed, Y Ferfar, S Pol… - Clinical …, 2019 - Elsevier
Background & Aims In small-size and short-term studies of hepatitis C virus–associated
cryoglobulinemia vasculitis (HCV-CryoVas), patients had a higher rate of response and …

[PDF][PDF] KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease

KDIGO Hepatitis C Work Group - Kidney International …, 2018 - discovery.ucl.ac.uk
The development and publication of this guideline were supported by KDIGO. The opinions
or views expressed in this professional education supplement are those of the authors and …

Cryoglobulinemia—One Name for Two Diseases

P Cacoub, M Vieira, D Saadoun - New England Journal of …, 2024 - Mass Medical Soc
Key Points Cryoglobulinemia The causes of cryoglobulinemias are currently restricted to a
few hematologic disorders, systemic autoimmune diseases, and chronic infections. The …

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection

M Ramos-Casals, AL Zignego, C Ferri, P Brito-Zerón… - Journal of …, 2017 - Elsevier
The hepatitis C virus (HCV), a linear, single-stranded RNA virus identified in 1989, is a
hepatotropic virus that causes liver cirrhosis and hepatocellular cancer and is a global …